Qube Research & Technologies Ltd

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1729829 LONDON, X0

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,145,090

-$5,646,861 QoQ

Shares Held

479,970

-48.4% QoQ

Ownership

0.361%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#26

of 279 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. AUPH ranks #54 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,145,090	479,970	-48.4%	Shares	Sole	2026-08-14
2026-03-31	$13,791,951	930,631	+6.4%	Shares	Sole	2026-05-15
2025-12-31	$13,945,802	874,345	-24.2%	Shares	Sole	2026-02-17
2025-09-30	$12,738,937	1,152,845	-7.2%	Shares	Sole	2025-11-14
2025-06-30	$10,524,076	1,242,512	+45.1%	Shares	Sole	2025-08-14
2025-03-31	$6,883,429	856,148	+337.3%	Shares	Sole	2025-05-15
2024-12-31	$1,757,915	195,759	+13.7%	Shares	Sole	2025-02-14
2024-03-31	$862,486	172,153	+141.2%	Shares	Sole	2024-05-14
2023-09-30	$554,607	71,378	+306.8%	Shares	Sole	2023-11-13
2022-12-31	$75,794	17,545	-84.3%	Shares	Sole	2023-02-14
2022-03-31	$1,384,195	111,809	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.